A client newly diagnosed with relapsing-remitting (RR) multiple sclerosis asks the nurse what this means. Which response is most accurate?

Rationale:
A. Fatigue is one of the most common and disabling symptoms of MS. Heat intolerance is frequent because elevated body temperature slows nerve conduction in demyelinated neurons, increasing fatigue and other MS symptoms. Resting in a cool environment helps the patient conserve energy, prevent exacerbation of symptoms, and maintain functional independence. Incorporating scheduled rest periods is a cornerstone of fatigue management in MS.

B. Planned short naps (20–30 minutes) can improve energy levels and cognitive function in patients with MS. Forbidding naps can lead to increased daytime sleepiness, decreased alertness, and overall worsening of fatigue, which negatively affects quality of life. Fatigue management focuses on energy conservation, not restricting rest.

C. Heat exposure can temporarily worsen MS symptoms through Uhthoff’s phenomenon, including fatigue, blurred vision, weakness, and numbness. Hot baths or showers may increase core body temperature, leading to transient worsening of fatigue and other neurologic symptoms. Cool or lukewarm water is generally recommended instead.

D. Cyclobenzaprine is a centrally acting muscle relaxant used to relieve skeletal muscle spasms. It does not address fatigue in MS and can cause sedation, dizziness, or lethargy, which may actually worsen fatigue. Fatigue management in MS relies on energy conservation strategies, activity pacing, and environmental modifications, not pharmacologic muscle relaxants.

Rationale:

A. On-off syndrome is a common complication of long-term Levodopa-Carbidopa therapy in Parkinson’s disease. Clients experience sudden, unpredictable fluctuations between periods of good mobility (“on” periods) and severe motor impairment or immobility (“off” periods). This occurs due to pulsatile dopaminergic stimulation and the short half-life of Levodopa, which leads to inconsistent dopamine receptor activation in the basal ganglia. Recognition and management (e.g., adjusting dosing schedules, using controlled-release formulations, or adding adjunct medications) are key to improving functional mobility.

B. Withdrawal syndrome refers to symptoms that occur after abrupt discontinuation of a medication, such as sudden worsening of Parkinsonian symptoms or life-threatening complications with drugs like baclofen. In this case, the client is still taking Levodopa, so this is not a withdrawal effect.

C. Rebound tremor refers to a temporary increase in tremor after a medication wears off or is rapidly discontinued. While related to motor fluctuations, it is not synonymous with the full immobility episodes seen in on-off syndrome. Rebound tremor is a specific component of motor fluctuation, not the broader phenomenon described here.

D. Acute dystonia involves sustained, involuntary muscle contractions causing abnormal postures, often occurring shortly after starting or increasing certain medications (e.g., antipsychotics). The client’s sudden “off” periods of immobility are not dystonic postures but generalized motor blockade, making dystonia an inappropriate description.